Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Moodys
Harvard Business School
Deloitte
Cantor Fitzgerald
Express Scripts
AstraZeneca
McKinsey
Fuji

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021301

« Back to Dashboard

NDA 021301 describes LEVOXYL, which is a drug marketed by King Pharms and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug. Additional details are available on the LEVOXYL profile page.

The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
Summary for 021301
Tradename:LEVOXYL
Applicant:King Pharms
Ingredient:levothyroxine sodium
Patents:3
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
Formulation / Manufacturing:see details
Pharmacology for NDA: 021301
Ingredient-typeThyroxine
Suppliers and Packaging for NDA: 021301
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVOXYL levothyroxine sodium TABLET;ORAL 021301 NDA Physicians Total Care, Inc. 54868-3849 E 54868-3849-1
LEVOXYL levothyroxine sodium TABLET;ORAL 021301 NDA Physicians Total Care, Inc. 54868-4087 E 54868-4087-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Approval Date:May 25, 2001TE:AB1,AB3RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Feb 15, 2022Product Flag?Substance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Feb 15, 2022Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Oct 2, 2023Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF USE OF ADMINISTERING LEVOTHYROXINE

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Queensland Health
McKesson
QuintilesIMS
Chinese Patent Office
Express Scripts
Cantor Fitzgerald
Merck
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.